![James Kelly](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
James Kelly
Financieel Directeur/CFO bij
NOVAVAX, INC.
Vermogen: 1 M $ op 31-05-2026
Profiel
Momenteel bekleedt James Patrick Kelly de functie van Chief Financial Officer, Treasurer & Executive VP van Novavax, Inc. Hij is tevens lid van The Association of Bioscience Financial Officers. In zijn vorige carrière bekleedde hij de functie van Chief Financial Officer, Treasurer & Executive VP voor Vanda Pharmaceuticals, Inc., Chief Financial Officer & Executive Vice President bij Supernus Pharmaceuticals, Inc., Director-Planning & Operations bij Biogen, Inc., Principal bij Aetna, Inc. en Vice President & Controller voor MedImmune LLC. De heer Kelly behaalde een MBA aan de Cornell University en een bachelorgraad aan de University of Vermont.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
NOVAVAX, INC. 0,08% | 23-04-2026 | 130.599 ( 0,08% ) | 1 M $ | 31-05-2026 |
Actieve functies van James Kelly
| Bedrijven | Functie | Begin |
|---|---|---|
| NOVAVAX, INC. | Financieel Directeur/CFO | 16-08-2021 |
The Association of Bioscience Financial Officers
 The Association of Bioscience Financial Officers Miscellaneous Commercial ServicesCommercial Services Operates as a association for bioscience financial officers | Corporate Officer/Principal | - |
Eerdere bekende functies van James Kelly
| Bedrijven | Functie | Einde |
|---|---|---|
| SUPERNUS PHARMACEUTICALS, INC. | Financieel Directeur/CFO | 13-08-2021 |
| VANDA PHARMACEUTICALS INC. | Financieel Directeur/CFO | 15-03-2020 |
MedImmune LLC
 MedImmune LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Comptroller/Controller/Auditor | 01-12-2010 |
| BIOGEN INC. | Corporate Officer/Principal | 01-11-2005 |
| AETNA | Corporate Officer/Principal | 01-06-2000 |
Opleiding van James Kelly
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
77
Eerstegraads connecties
9
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 9 |
|---|---|
MedImmune LLC
MedImmune LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
Biogen, Inc.
 Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
Novavax, Inc.
 Novavax, Inc. BiotechnologyHealth Technology Engages in development of novel recombinant vaccines | Health Technology |
Aetna, Inc.
 Aetna, Inc. Managed Health CareHealth Services Provides health insurance plans services | Health Services |
Vanda Pharmaceuticals, Inc.
 Vanda Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company, which focuses on the development and commercialization of therapies | Health Technology |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Vermont
 University of Vermont Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Supernus Pharmaceuticals, Inc.
 Supernus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products for the treatment of central nervous system diseases | Health Technology |
The Association of Bioscience Financial Officers
The Association of Bioscience Financial Officers Miscellaneous Commercial ServicesCommercial Services Operates as a association for bioscience financial officers | Commercial Services |
